MedTrace Logo

Retrospective Study to Capture Dosing and Treatment Outcome Data in Participants With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND

NCT00161720 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2021-04-08

No results posted yet for this study

Summary

This is a data collection study with the purpose of capturing dosing and treatment outcome data in participants with severe congenital protein C deficiency who were treated with protein C concentrate under an Emergency Use Investigational New Drug Application (IND).

Conditions

  • Protein C Deficiency

Interventions

DRUG

Protein C Concentrate (Human) Vapor Heated

Protein C Concentrate (Human) Vapor Heated

Sponsors & Collaborators

  • Baxalta now part of Shire

    lead INDUSTRY

Principal Investigators

  • Study Director · Takeda

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-01
Primary Completion
2005-12-01
Completion
2005-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00161720 on ClinicalTrials.gov